HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.17T | 29.82% |
Operating expense | 17.16B | -7.85% |
Net income | 106.29B | 55.47% |
Net profit margin | 9.05 | 19.71% |
Earnings per share | — | — |
EBITDA | 140.45B | 49.99% |
Effective tax rate | 23.29% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 264.27B | 109.45% |
Total assets | 2.14T | 23.23% |
Total liabilities | 870.07B | 21.34% |
Total equity | 1.27T | — |
Shares outstanding | 3.60M | — |
Price to book | 0.08 | — |
Return on assets | 16.50% | — |
Return on capital | 27.44% | — |
Cash Flow
Net change in cash
| (IDR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 106.29B | 55.47% |
Cash from operations | 115.29B | 498.15% |
Cash from investing | -6.96B | 66.09% |
Cash from financing | -773.67M | -3.00% |
Net change in cash | 106.80B | 5,790.28% |
Free cash flow | 73.95B | 352.14% |
About
Founded
1972
Website
Employees
173
